We are live on ! Find out more
AEMD icon

Aethlon Medical

7 hedge funds and large institutions have $851K invested in Aethlon Medical in 2017 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0%0% (-0%)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

22% less funds holding

Funds holding: 97 (-2)

55% less capital invested

Capital invested by funds: $1.88M → $851K (-$1.03M)

Holders
7
Holders Change
-2
Holders Change %
-22.22%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

AEMD Hedge Fund Activity: Q1 2017 in Review

7 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q1 2017, worth a combined $851K — down 55% from $1.88M a quarter earlier.

Fund positioning in AEMD was balanced in Q1 2017: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $278K. The largest seller was Cordasco Financial Network, exiting entirely with an estimated $857K sold.

  • 7 institutional investors held Aethlon Medical (AEMD) as of Q1 2017, down from 9 in Q4 2016.
  • Funds reported $851K of Aethlon Medical stock for Q1 2017, down 55% quarter-over-quarter.
  • 2 funds opened new Aethlon Medical positions in Q1 2017 and 2 closed out, a net change of 0 holders.
  • The largest Aethlon Medical buyer in Q1 2017 was BlackRock, an estimated $278K added.
  • The largest Aethlon Medical seller in Q1 2017 was Cordasco Financial Network, an estimated $857K sold.

Based on aggregated 13F filings for Q1 2017.